| Ticker Details |
|
Vivos Therapeutics, Inc.
|
| IPO Date: |
July 7, 2020 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$18.61M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 5.00%
|
| Avg Daily Range (30 D): |
$0.07 | 3.88%
|
| Avg Daily Range (90 D): |
$0.08 | 3.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.32M |
| Avg Daily Volume (30 D): |
.12M |
| Avg Daily Volume (90 D): |
.14M |
| Trade Size |
| Avg Trade Size (Sh.): |
91 |
| Avg Trade Size (Sh.) (30 D): |
167 |
| Avg Trade Size (Sh.) (90 D): |
197 |
| Institutional Trades |
| Total Institutional Trades: |
25 |
| Avg Institutional Trade: |
$.96M |
| Avg Institutional Trade (30 D): |
$.65M |
| Avg Institutional Trade (90 D): |
$.65M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.05M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$.84M |
| Avg Closing Volume: |
12.46K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.77
|
$-.49
|
$-.55
|
|
Diluted EPS
|
$-1.77
|
$-.49
|
$-.55
|
|
Revenue
|
$17.32M
|
$6.78M
|
$3.82M
|
|
Gross Profit
|
$9.65M
|
$3.94M
|
$2.11M
|
|
Net Income / Loss
|
$-17.1M
|
$-5.4M
|
$-5.01M
|
|
Operating Income / Loss
|
$-16.32M
|
$-4.73M
|
$-4.87M
|
|
Cost of Revenue
|
$7.66M
|
$2.85M
|
$1.71M
|
|
Net Cash Flow
|
$-3.22M
|
$-1.32M
|
$-1.86M
|
|
PE Ratio
|
|
|
|
|
|
|